DBDavid BackPhDSlidesetHIVRio de Janeiro HIV Clinical Forum 2018Future perspective for delivery of antiretroviral drugs | David Back, PhDView Slideset
PCPedro CahnMD, PhDSlidesetHIVRio de Janeiro HIV Clinical Forum 2018Simplified regimens: pros and cons | Pedro Cahn, MD, PhDView Slideset
CBCarlos BritesMD, PhDSlidesetHIVRio de Janeiro HIV Clinical Forum 2018Optimal use of INSTI’s in routine practice | Carlos Brites, MD, PhDView Slideset
TVTânia VergaraMD, PhDSlidesetHIVRio de Janeiro HIV Clinical Forum 2018Clinical case presentation | Tânia Vergara, MD, PhDView Slideset
MSMauro SchechterMD, PhDSlidesetHIVRio de Janeiro HIV Clinical Forum 2018SIERJ SESSION: Is early ART for everyone? | Mauro Schechter, MD, PhDView Slideset
SlidesetHIVRio de Janeiro HIV Clinical Forum 2018Clinical case presentation | Marcio de Figueiredo Fernandes, MDView Slideset
SlidesetHIVMexican HIV Clinical Forum 2018Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmDView Slideset
SlidesetHIVMexican HIV Clinical Forum 2018Clinical case presentation | Santiago Pérez Patrigeon, PhDView Slideset
SlidesetHIVMexican HIV Clinical Forum 2018HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhDView Slideset
SlidesetHIVMexican HIV Clinical Forum 2018Integrase Inhibitors in Women and Pediatrics | Alberto Chaparro-Sánchez, MDView Slideset
SlidesetHIVMexican HIV Clinical Forum 2018Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico | Luis Soto-Ramirez, MDView Slideset
